Sakura Holloway

Investment Analyst

MSc, Patent Attorney







Sakura brings a unique blend of skills that include a strong technical background in biological sciences, including immunology and molecular biology combined with intellectual property and commercial experience. Sakura has held business development and IP counsel positions in medical research institutes, and public and private biotechnology companies. Most recently Sakura was Chief IP counsel at Benitec Biopharma Ltd (Nasdaq: BNTC) where she was an integral team member in the Company’s US Nasdaq IPO. Prior to this position she held positions as head of commercialization for RNAi technology at CSIRO, and Business Development and IP manager at the Garvan Institute of Medical Research. Sakura also held the position of Director of IP at Cephalon Australia Pty Ltd (formerly Arana Therapeutics).

Sakura is a graduate of UTS with Bachelor of Science (Biomedical Science), Master of Science and Master of Intellectual property. She is also a registered patent attorney.